Blume Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.6M Buy
20,414
+20,114
+6,705% +$1.62M 0.23% 71
2026
Q1
$26K Buy
+300
New +$28.7K ﹤0.01% 229
2025
Q1
Sell
-19,128
Closed -$1.53M 460
2024
Q4
$1.53M Sell
19,128
-1,420
-7% -$123K 0.34% 56
2024
Q3
$1.85M Buy
20,548
+500
+2% +$42.1K 0.41% 53
2024
Q2
$1.58M Buy
20,048
+2,158
+12% +$177K 0.38% 53
2024
Q1
$1.56M Buy
17,890
+50
+0.3% +$4.27K 0.38% 51
2023
Q4
$1.47M Buy
17,840
+9,000
+102% +$686K 0.38% 51
2023
Q3
$693K Buy
+8,840
New +$740K 0.21% 63
2023
Q2
Sell
-300
Closed -$24.2K 328
2023
Q1
$24.2K Sell
300
-400
-57% -$32.6K 0.01% 202
2022
Q4
$54.4K Hold
700
0.02% 161
2022
Q3
$57K Sell
700
-749
-52% -$67.3K 0.02% 148
2022
Q2
$130K Buy
1,449
+265
+22% +$26.9K 0.05% 103
2022
Q1
$131K Sell
1,184
-150
-11% -$15.8K 0.04% 108
2021
Q4
$138K Hold
1,334
0.05% 118
2021
Q3
$167K Buy
1,334
+234
+21% +$30.3K 0.06% 94
2021
Q2
$137K Hold
1,100
0.05% 103
2021
Q1
$130K Buy
+1,100
New +$129K 0.05% 99
2016
Q2
Sell
-600
Closed -$45K 232
2016
Q1
$45K Hold
600
0.03% 100
2015
Q4
$46K Hold
600
0.03% 112
2015
Q3
$40K Hold
600
0.03% 109
2015
Q2
$44K Sell
600
-1,200
-67% -$91.7K 0.03% 119
2015
Q1
$140K Hold
1,800
0.1% 62
2014
Q4
$130K Buy
1,800
+1,200
+200% +$83.4K 0.09% 72
2014
Q3
$37K Hold
600
0.03% 109
2014
Q2
$38K Hold
600
0.03% 115
2014
Q1
$37K Hold
600
0.03% 125
2013
Q4
$34K Buy
+600
New +$34K 0.03% 144

Other funds holding MDT

Blume Capital Management's MDT Position: Q2 2026 in Review

Blume Capital Management increased its Medtronic (MDT) stake by 6,705% in Q2 2026, buying an estimated $1.62M and bringing the position to 20,414 shares worth $1.6M. The position accounts for 0.23% of the portfolio, ranked #71.

Blume Capital Management first reported a position in MDT in Q4 2013 and has held it in 27 quarters since. The position peaked at $1.85M in Q3 2024. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Blume Capital Management held 20,414 shares of Medtronic worth $1.6M as of Q2 2026.
  • Blume Capital Management bought 20,114 Medtronic shares in Q2 2026, an estimated $1.62M.
  • Medtronic made up 0.23% of Blume Capital Management's portfolio in Q2 2026, its #71 holding.
  • Blume Capital Management first reported a position in Medtronic in Q4 2013 and has held it in 27 quarters since.
  • Blume Capital Management's Medtronic position peaked at $1.85M in Q3 2024.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Blume Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.